These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 7935378)
1. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Perkins ND; Agranoff AB; Pascal E; Nabel GJ Mol Cell Biol; 1994 Oct; 14(10):6570-83. PubMed ID: 7935378 [TBL] [Abstract][Full Text] [Related]
2. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080 [TBL] [Abstract][Full Text] [Related]
3. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Majello B; De Luca P; Hagen G; Suske G; Lania L Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480 [TBL] [Abstract][Full Text] [Related]
4. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Desai-Yajnik V; Samuels HH Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143 [TBL] [Abstract][Full Text] [Related]
5. Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia. Granelli-Piperno A; Pope M; Inaba K; Steinman RM Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10944-8. PubMed ID: 7479915 [TBL] [Abstract][Full Text] [Related]
7. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Pazin MJ; Sheridan PL; Cannon K; Cao Z; Keck JG; Kadonaga JT; Jones KA Genes Dev; 1996 Jan; 10(1):37-49. PubMed ID: 8557193 [TBL] [Abstract][Full Text] [Related]
8. Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3). Duckett CS; Perkins ND; Kowalik TF; Schmid RM; Huang ES; Baldwin AS; Nabel GJ Mol Cell Biol; 1993 Mar; 13(3):1315-22. PubMed ID: 8441377 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1. Chapman NR; Perkins ND J Biol Chem; 2000 Feb; 275(7):4719-25. PubMed ID: 10671503 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [TBL] [Abstract][Full Text] [Related]
11. In vitro study of functional involvement of Sp1, NF-kappa B/Rel, and AP1 in phorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation. Li Y; Mak G; Franza BR J Biol Chem; 1994 Dec; 269(48):30616-9. PubMed ID: 7982981 [TBL] [Abstract][Full Text] [Related]
12. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. Subler MA; Martin DW; Deb S J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719 [TBL] [Abstract][Full Text] [Related]
13. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor. Hansen SK; Guerrini L; Blasi F J Biol Chem; 1994 Sep; 269(35):22230-7. PubMed ID: 8071349 [TBL] [Abstract][Full Text] [Related]
14. RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions. Takada N; Sanda T; Okamoto H; Yang JP; Asamitsu K; Sarol L; Kimura G; Uranishi H; Tetsuka T; Okamoto T J Virol; 2002 Aug; 76(16):8019-30. PubMed ID: 12134007 [TBL] [Abstract][Full Text] [Related]
16. Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. Ross EK; Buckler-White AJ; Rabson AB; Englund G; Martin MA J Virol; 1991 Aug; 65(8):4350-8. PubMed ID: 2072454 [TBL] [Abstract][Full Text] [Related]
17. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. Yurochko AD; Mayo MW; Poma EE; Baldwin AS; Huang ES J Virol; 1997 Jun; 71(6):4638-48. PubMed ID: 9151857 [TBL] [Abstract][Full Text] [Related]
18. Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes. Parrott C; Seidner T; Duh E; Leonard J; Theodore TS; Buckler-White A; Martin MA; Rabson AB J Virol; 1991 Mar; 65(3):1414-9. PubMed ID: 1995951 [TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. Chang LJ; McNulty E; Martin M J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644 [TBL] [Abstract][Full Text] [Related]
20. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Kamine J; Subramanian T; Chinnadurai G Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]